Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PAFAH1B3 contributors: mct - updated : 28-04-2012
HGNC name platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit 29kDa
HGNC id 8576
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
6 - 869 29 231 - -
6 - 1108 - 231 - -
6 - 1086 29 231 - -
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart   highly
Endocrineneuroendocrinepituitary  highly
Nervousbrain   highly Homo sapiens
 nervecranial nerve  highly
cell lineage
cell lines
fluid/secretion
at STAGE
Text brain
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
mono polymer heteromer , dimer
HOMOLOGY
Homologene
FAMILY platelet-activating factor acetylhydrolase Ib beta/gamma subunits family
CATEGORY enzyme
SUBCELLULAR LOCALIZATION     intracellular
intracellular,cytoplasm,organelle,endosome
text located on early-sorting endosomes and the central endocytic recycling compartment (ERC) 1)
basic FUNCTION
  • inactivator of PAF, by removing the acetyl group at the SN-2 position
  • plays an important role during the development of brain
  • potent regulator of platelet activating factor activity, plays an important role in various physiological and pathophysiological functions including development, reproduction, inflammation, hemostasis, and apoptosis
  • PAFAh1B2 and PAFAH1B3 have profoundly different effects on brain development and interact in a significantly different manner with the Reelin signaling pathway
  • antagonistic effect of PAFAH1B2, PAFAH1B3 and NDEL1 for PAFAH1B1 binding, probably to modulate dynein functions
  • PAFAH1B2 and PAFAH1B3 expression levels affect the distribution of endosomes within the cell through interactions with the dynein regulator PAFAH1B1
  • PAFAH Ib regulates endocytic membrane trafficking through novel mechanisms involving both PLA(2) activity and PAFAH1B1-dependent dynein function
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • formed of three subunits of 45 kDa (alpha), 30 kDa (beta) and 29kDa (gamma)
  • PAFAH1B catalytic subunit
  • tetramer of two catalytic subunits, ALPHA1 (PAFAH1B3) and ALPHA2 (PAFAH1B2), and a regulatory dimer of LIS1 (PAFAH1B1)
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binds the Reelin receptor VLDLR
  • PAFAH1B3 and PAFAH1B2, were able to compete against NDEL1 and dynein for PAFAH1B1 binding in a dose-dependent manner (
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) MRAA
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS